This ongoing treatment study examines the efficacy of CBD oil within the context of a randomized placebo-controlled clinical trial. Subjects (N = 150) meeting DSM-5 criteria for PTSD are randomized to one of the following three conditions: (a) 300 mg of CBD isolate; (b) 300 mg of CBD broad spectrum oil; or (c) placebo oil. All patients undergo a comprehensive battery of PTSD-related symptom measures on three separate occasions (pretreatment (Week 0), posttreatment (Week 9), and 1 month follow-up (Week 13). Additional information about the study is available on www.ClinicalTrials.gov. More information about the Laboratory for the Study of Anxiety Disorders is available on our website at https://www.UTAnxiety.com.
Able to commit 10 hrs per week Good communication skills Good organizational skills Capable of interacting with people in emotional distress Experience with using UT Qualtrics (Advantageous but not required)
This project is currently ongoing.
Administer structured phone interviews with potential patients Administer computer-based questionnaires Scheduling and tracking patient appointments
